73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy
Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ
ACE inhibitor not protective against heart damage from chemotherapy

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin
Novel drug combination shows promise for advanced HER2-negative breast cancer

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a
Early menopause appears raise odds of breast cancer, study reports

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear
Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia
State-of-the-art MRI technology bypasses need for biopsy

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI
Study offers new understanding of why kidney cancers become metastatic

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi
Cancer of the appendix: Very rare, but genes may play role

Cancer of the appendix: Very rare, but genes may play role

by Cara MurezWhile appendix cancer is rare, for a small percentage of patients the disease may be linked to a particular genetic variant, a new study suggests.Researchers built on earlier research wit

Cancer of the appendix: Very rare, but genes may play role

by Cara MurezWhile appendix cancer is rare, for a small percentage of patients the disease may be linked to a particular genetic variant, a new study suggests.Researchers built on earlier research wit
Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo
Tailored online personal health record cancer tool increases survivor adherence to national guidelines

Tailored online personal health record cancer tool increases survivor adherence to national guidelines

byRegenstrief InstituteScreenshot of personal health record, “My Follow-up Care” Dashboard. CEA: carcinoembryonic antigen; CT: computed tomography. Credit:JMIR Cancer(2022). DOI: 10.

Tailored online personal health record cancer tool increases survivor adherence to national guidelines

byRegenstrief InstituteScreenshot of personal health record, “My Follow-up Care” Dashboard. CEA: carcinoembryonic antigen; CT: computed tomography. Credit:JMIR Cancer(2022). DOI: 10.
Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

by Impact Journals LLCRole for ABCB1 in PDAC chemoresistance. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28597A new editorial paper titled "Targeting ABC transporters in PDAC—p

Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

by Impact Journals LLCRole for ABCB1 in PDAC chemoresistance. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28597A new editorial paper titled "Targeting ABC transporters in PDAC—p